News
SenesTech Announces Record First Quarter 2022 Product Sales
Sales up 122% Company Launches New Elevate Bait System™ with ContraPest® PHOENIX, May 12, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered...
SenesTech to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, May 5, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2022, ended March 31, 2022, after the market close on...
SenesTech, Inc. to Participate in the Lytham Partners Spring 2022 Investor Conference
PHOENIX, March 31, 2022 -- SenesTech, Inc. (NASDAQ: SNES) announced today that it will be participating in the Lytham Partners Spring 2022 Investor Conference taking place virtually on April 4-7, 2022. The Company's webcast presentation will be available for viewing...
SenesTech Announces Year-End 2021 Financial and Operational Results
Product Sales up 123% as the Company Drives ContraPest® Deployment in New and Existing Market Verticals PHOENIX, March 29, 2022 -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors...
SenesTech to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Tuesday, March 29, 2022
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX, March 23, 2022 -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2021, ended December 31, 2021, after the...
SenesTech, Inc., Announces EPA Approval and Launch of the Elevate Bait System™ with ContraPest®
The Elevate Bait System with ContraPest is specifically designed to address rat problems in above-ground locations. PHOENIX, March 22, 2022 -- SenesTech, Inc., (SNES) announced today the EPA approval of and launch of its newest product design and application, the...
SenesTech Announces ContraPest® Deployment at a Major Correctional Facility
ContraPest®, the one and only EPA approved birth control product for rats, addresses the unique challenges controlling rat populations in this unique customer segment.PHOENIX, Feb. 24, 2022 -- SenesTech, Inc. (NASDAQ: SNES) (www.senestech.com), the rodent...
SenesTech Announces ContraPest® Deployment at California Wildlife Preserve
Latest in a growing number of deployments in the zoo and animal sanctuary market. ContraPest®, the one and only EPA approved birth control product for rats, addresses the unique challenges controlling rat populations in animal settings.PHOENIX, Feb. 3, 2022 --...
Columbus, Ohio Joins a Growing Number of Cities Across the United States Deploying SenesTech’s ContraPest® as Part of Their Pest Management Programs
PHOENIX, Jan. 25, 2022 -- SenesTech (NASDAQ: SNES) (www.senestech.com), the rodent fertility control expert, announced today that Columbus, Ohio is the latest city to begin using ContraPest®. Columbus now joins cities like San Francisco, Washington DC, Hartford,...
Los Angeles County To Require Rat Fertility Control be Part of its Pest Management Program Moving Forward as it Works to Combat Soaring Rat Populations
SenesTech's ContraPest® is the only EPA registered fertility control product for ratsPHOENIX, Jan. 21, 2022 -- SenesTech (NASDAQ: SNES) (www.senestech.com), the rodent fertility control expert, noted today that Los Angeles County, one of the largest counties in...